Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo hemorrhagic fever virus, Journal of General Virology, vol.86, issue.12, pp.3327-3336, 2005. ,
DOI : 10.1099/vir.0.81175-0
Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice, Vaccine, vol.24, issue.14, pp.2477-2490, 2006. ,
DOI : 10.1016/j.vaccine.2005.12.057
G2 murine serum with both plant-made G1/G2 glycoprotein and CCHF vaccine containing inactivated CCHF virus as antigen determined by ELISA and Western blotting. (a) The ELISA shows that anti-G1/G2 IgG antibodies in serum reacted with both antigens. (b) Illustration of crossreaction of the antiserum with both antigens by Western blot analysis. Lane 1, CCHF vaccine containing inactivated CCHF virus ,
Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice, Plant Science, vol.180, issue.4, pp.620-627, 2011. ,
DOI : 10.1016/j.plantsci.2011.01.004
Effective Plague Vaccination via Oral Delivery of Plant Cells Expressing F1-V Antigens in Chloroplasts, Infection and Immunity, vol.76, issue.8, pp.3640-3650, 2008. ,
DOI : 10.1128/IAI.00050-08
Pathogenesis and Immune Response of Crimean-Congo Hemorrhagic Fever Virus in a STAT-1 Knockout Mouse Model, Journal of Virology, vol.84, issue.21, pp.11089-11100, 2010. ,
DOI : 10.1128/JVI.01383-10
Cellular Localization and Antigenic Characterization of Crimean-Congo Hemorrhagic Fever Virus Glycoproteins, Journal of Virology, vol.79, issue.10, pp.6152-6161, 2005. ,
DOI : 10.1128/JVI.79.10.6152-6161.2005
Production of recombinant proteins in plant root exudates, Nat. Biotechnol, vol.17, pp.466-469, 1999. ,
Therapeutic Manipulation of the Immune System: Enhancement of Innate and Adaptive Mucosal Immunity, Current Pharmaceutical Design, vol.9, issue.24, pp.1965-1972, 2003. ,
DOI : 10.2174/1381612033454225
Effective Mucosal Immunity to Anthrax: Neutralizing Antibodies and Th Cell Responses Following Nasal Immunization with Protective Antigen, The Journal of Immunology, vol.170, issue.11, pp.5636-5643, 2003. ,
DOI : 10.4049/jimmunol.170.11.5636
The rational design of vaccines, Drug Discovery Today, vol.10, issue.22, pp.1527-1534, 2005. ,
DOI : 10.1016/S1359-6446(05)03600-7
Molecular epidemiology of African and Asian Crimean-Congo haemorrhagic fever isolates, Epidemiology and Infection, vol.133, issue.4, pp.659-666, 2005. ,
DOI : 10.1017/S0950268805003730
Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebrates, Epidemiology and Infection, vol.44, issue.03, pp.547-557, 1993. ,
DOI : 10.1159/000149421
Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant, Veterinary Immunology and Immunopathology, vol.135, issue.3-4, pp.234-242, 2010. ,
DOI : 10.1016/j.vetimm.2009.12.003
Plant-made vaccine antigens and biopharmaceuticals, Trends in Plant Science, vol.14, issue.12, pp.669-679, 2009. ,
DOI : 10.1016/j.tplants.2009.09.009
Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice, Plant Biotechnol. J, vol.6, pp.930-940, 2008. ,
A plant DNA minipreparation: Version II, Plant Molecular Biology Reporter, vol.3, issue.4, pp.19-21, 1983. ,
DOI : 10.1007/BF02712670
Crimean-Congo Hemorrhagic Fever Virus Genomics and Global Diversity, Journal of Virology, vol.80, issue.17, pp.8834-8842, 2006. ,
DOI : 10.1128/JVI.00752-06
Purification and characterization of a viral chitinase active against plant pathogens and herbivores from transgenic tobacco, Journal of Biotechnology, vol.147, issue.1, pp.1-6, 2010. ,
DOI : 10.1016/j.jbiotec.2010.03.005
Generation of transgenic plants expressing antibodies to the environmental pollutant microcystin-LR, The FASEB Journal, vol.24, issue.3, pp.882-890, 2010. ,
DOI : 10.1096/fj.09-140848
Crimean-Congo haemorrhagic fever, The Lancet Infectious Diseases, vol.6, issue.4, pp.203-214, 2006. ,
DOI : 10.1016/S1473-3099(06)70435-2
Treatment of Crimean-Congo hemorrhagic fever, Antiviral Research, vol.78, issue.1, pp.125-131, 2008. ,
DOI : 10.1016/j.antiviral.2007.11.002
Crimean-Congo Hemorrhagic Fever Virus, Current Molecular Medicine, vol.5, issue.8, pp.753-760, 2005. ,
DOI : 10.2174/156652405774962335
Prospects for immunisation against Marburg and Ebola viruses, Reviews in Medical Virology, vol.78, issue.Suppl 2, pp.344-357, 2010. ,
DOI : 10.1002/rmv.661
Review Article: The Epidemiology of Tick-Borne Crimean-Congo Hemorrhagic Fever in Asia, Europe, and Africa, Journal of Medical Entomology, vol.15, issue.4, pp.307-417, 1979. ,
DOI : 10.1093/jmedent/15.4.307
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice, Vaccine, vol.29, issue.16, pp.2968-2977, 2011. ,
DOI : 10.1016/j.vaccine.2011.01.113
Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells, Vaccine, vol.27, issue.35, pp.4798-4807, 2009. ,
DOI : 10.1016/j.vaccine.2009.05.092
URL : https://hal.archives-ouvertes.fr/pasteur-00460443
Mucosal Immunity to Infections and its Importance in Future Vaccinology, Adv. Exp. Med. Biol, vol.549, pp.13-22, 2004. ,
DOI : 10.1007/978-1-4419-8993-2_4
Vaccine development strategies for improving immunization: the role of modern immunology, Nature Immunology, vol.5, issue.5, pp.460-464, 2004. ,
DOI : 10.1038/ni0504-460
Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations, Virology, vol.356, issue.1-2, pp.171-178, 2006. ,
DOI : 10.1016/j.virol.2006.07.045
Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness, Euro. Surveill, vol.15, 2010. ,
Transgenic plants as vaccine production systems, Trends in Biotechnology, vol.13, issue.9, pp.388-392, 1995. ,
DOI : 10.1016/S0167-7799(00)88986-6
Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene, Vaccine, vol.16, issue.13, pp.1336-1343, 1998. ,
DOI : 10.1016/S0264-410X(98)80020-0
Immunization against rabies with plant-derived antigen, Proceedings of the National Academy of Sciences, vol.95, issue.5, pp.2481-2485, 1998. ,
DOI : 10.1073/pnas.95.5.2481
Mucosal vaccines: the promise and the challenge, Nature Reviews Immunology, vol.74, issue.2, pp.148-158, 2006. ,
DOI : 10.1038/nri1777
The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain. Scand, J. Infect. Dis, vol.43, pp.225-229, 2011. ,
Investigating recombinant protein exudation from roots of transgenic tobacco, Environmental Biosafety Research, vol.7, issue.4, pp.219-226, 2008. ,
DOI : 10.1051/ebr:2008020
vaccine development, Human Vaccines, vol.6, issue.6, pp.439-449, 2010. ,
DOI : 10.4161/hv.6.6.11097
Rabies glycoprotein fused with B subunit of cholera toxin expressed in tobacco plants folds into biologically active pentameric protein, Protein Expression and Purification, vol.70, issue.2, pp.184-190, 2010. ,
DOI : 10.1016/j.pep.2009.10.002
Molecular cloning: a laboratory manual, 2001. ,
Characterization of the Glycoproteins of Crimean-Congo Hemorrhagic Fever Virus, Journal of Virology, vol.76, issue.14, pp.7263-7275, 2002. ,
DOI : 10.1128/JVI.76.14.7263-7275.2002
Clinical features of crimean-congo haemorrhagic fever in the united arab emirates, Infection, vol.22, issue.Suppl. 4, pp.364-367, 1997. ,
DOI : 10.1007/BF01740819
Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus, Vaccine, vol.24, issue.21, pp.4657-4666, 2006. ,
DOI : 10.1016/j.vaccine.2005.08.034
Mucosal immunization using recombinant plant-based oral vaccines, Methods, vol.38, issue.2, pp.150-157, 2006. ,
DOI : 10.1016/j.ymeth.2005.09.013
Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPs, PLoS Medicine, vol.79, issue.6, p.177, 2006. ,
DOI : 10.1371/journal.pmed.0030177.sd001
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato, Nature Medicine, vol.11, issue.5, pp.607-609, 1998. ,
DOI : 10.1038/351371a0
The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising, European Journal of Clinical Microbiology & Infectious Diseases, vol.36, issue.12, pp.929-933, 2009. ,
DOI : 10.1007/s10096-009-0728-2
Immunogenicity in humans of an edible vaccine for hepatitis B, Proceedings of the National Academy of Sciences, vol.102, issue.9, pp.3378-3382, 2005. ,
DOI : 10.1073/pnas.0409899102
Tobacco Transformation, Methods Mol. Biol, vol.81, pp.365-372, 1998. ,
DOI : 10.1385/0-89603-385-6:365
Crimean???Congo hemorrhagic fever, Antiviral Research, vol.64, issue.3, pp.145-160, 2004. ,
DOI : 10.1016/S0166-3542(04)00163-9
Hairy-root organ cultures for the production of human acetylcholinesterase, BMC Biotechnology, vol.8, issue.1, p.95, 2008. ,
DOI : 10.1186/1472-6750-8-95
Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China, Am. J. Trop. Med. Hyg, vol.34, pp.1179-1182, 1985. ,